BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer (Q84540462)
Jump to navigation
Jump to search
scientific article published on 05 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer |
scientific article published on 05 July 2012 |
Statements
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer (English)
A Gonçalves
M Gilabert
E François
L Dahan
H Perrier
R Lamy
D Re
R Largillier
M Gasmi
X Tchiknavorian
B Esterni
D Genre
L Moureau-Zabotto
M Giovannini
J-F Seitz
O Turrini